Protai logo

Protai

Proteomics & AI Drug discovery

29 employees · est. 2021 · Israel

VS
Rezo Therapeutics logo

Rezo Therapeutics

Revolutionizing Drug Discovery by Mapping Biological Networks

43 employees · est. 2021 · San Francisco, United States

Side-by-Side Comparison

Protai Rezo Therapeutics
Founded
2021 2021
Headquarters
Israel San Francisco, United States
Employees
29 43
Industry
AI, Biotechnology, Life Sciences Not tracked yet
Funding Stage
Seed Series A
Total Funding
$20.00M $78.00M
Funding Rounds
2 1
Services
Structural Proteomics Integration, AI-Driven Drug Discovery, Pipeline Development, End-to-End Drug Discovery Collaboration, AIMS™ Platform Utilization Mapping Disease Networks, Drug Discovery Research, Therapeutics Development
Target Customers
Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Innovators, Partnering Enterprises Pharmaceutical Companies, Biotechnology Firms, Healthcare Professionals, Research Institutions
Taxonomy
Proteomics, AI Drug Discovery, End-to-End AI Platform, Cellular Function Analysis, Biological Insights, Complex Disease Combat, Protein Level Mapping, Drug Candidate Creation, Drug Discovery Facilitation, Advanced Drug Discovery, Disease Mapping, Molecular Biology, Pharmaceutical Innovation, Biotech Network Biology, Drug Discovery, Biopharma, Oncology, Disease-agnostic Platform, Biotech Innovation, Therapeutic Discovery, Target Identification, Integrated Biology Platform, Academic Leadership, FDA Approvals, Collaborations, Proprietary Technology, Scientific Breakthroughs
Website
protai.bio rezotx.com
Protai logo

About Protai

Protai, founded in 2021 and headquartered in Israel, leverages cutting-edge technologies in AI, Biotechnology, and Life Sciences to revolutionize drug discovery. By utilizing an AI-based platform, Protai delves into the proteomic landscape to map diseases at the protein level, offering a novel appro...

Rezo Therapeutics logo

About Rezo Therapeutics

Rezo Therapeutics is a pioneering company in the biotech space, committed to revolutionizing drug discovery by addressing the inherent complexities of human disease through a novel platform approach. Established in 2021 and headquartered in the United States, Rezo aims to transcend traditional metho...

We will tell you when either one moves

BounceWatch watches Protai and Rezo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Protai and Rezo Therapeutics — by email.

Frequently Asked Questions

Protai — Proteomics & AI Drug discovery . Rezo Therapeutics — Revolutionizing Drug Discovery by Mapping Biological Networks. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Protai has raised $20.00M while Rezo Therapeutics has raised $78.00M.
Protai and Rezo Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Protai with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Protai on 15 Jun 2026, and Rezo Therapeutics on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy